This year, World Lung Day is on Saturday, September 25. Established by The Forum of International Respiratory Societies (FIRS), this annual lung health awareness day is an opportunity for the global community to promote better lung health, advocacy and action. It’s also a chance for organizations from around the globe to discuss how they can better work together to rid the world of all lung disease.
The Open Source Imaging Consortium (OSIC) is proud to be a part of that conversation. OSIC was created to look at lung diseases differently, with the goal of making rapid progress in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing ILDs, and other respiratory diseases, including emphysematous conditions. And we know that the only way to create a world free of lung disease is through collaboration.
We recently launched the OSIC Data Repository, a global database of anonymized HRCT scans and clinical information regarding ILDs. It is driven by experts in pulmonology, radiology and artificial intelligence, and is the largest and most diverse database of its kind. It is our belief that this database could be the start of finding digital imaging biomarkers that could potentially speed up diagnosis, and aid in better understanding of individual prognosis and response to therapy.
“Building the OSIC repository has been a collaboration in its truest sense, with people from different disciplines, organizations, and countries all coming together on behalf of patients everywhere. This ability to collect and organize anonymized imaging and clinical data from across the world is the future of clinical science,” said Dr. Kevin Brown, National Jewish Health & OSIC pulmonology lead. “We’ve seen efforts like this in common diseases, but nothing truly like it for rare diseases. As the OSIC database grows and we continuously learn from it, a real and substantial improvement in our ability to diagnose early, to predict outcomes, and to measure responses to therapy will be the result.”
In honor of World Lung Day, we encourage all of you to continue collaborating on behalf of the countless patients around the world living with lung disease. By bringing together brilliant minds and innovative thinkers from every corner of the globe, we know we can make progress!